Kelvin Stott

Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.

Kelvin Stott, Jonathan M. Blackburn, P J Butler et al. · Proceedings of the National Academy of Sciences · 1995 · 223 citations · Full text

Expanded Glutamine Repeats, Protein Assembly, Genetics +20

N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure

Nicoleta Kokkoni, Kelvin Stott, Hozefa Amijee et al. · Biochemistry · 2006 · 187 citations

Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat

Yu Wai Chen, Kelvin Stott, M. F. Perutz · Proceedings of the National Academy of Sciences · 1999 · 64 citations · Full text

Improving the assessment of the probability of success in late stage drug development

Lisa V. Hampson, Björn Bornkamp, Björn Holzhauer et al. · Pharmaceutical Statistics · 2021 · 18 citations

Clinical Endpoint, Pharmacotherapy, Drug Assessment +21

Solution Studies of Chymotrypsin Inhibitor-2 Glutamine Insertion Mutants Show No Interglutamine Interactions

Duncan J. Gordon-Smith, Rodrigo J. Carbajo, Kelvin Stott et al. · Biochemical and Biophysical Research Communications · 2001 · 17 citations

Molecular Pharmacology, Biochemistry, G Protein-coupled Receptor +3